⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iii adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8

Every month we try and update this database with for stage iii adrenal gland pheochromocytoma and sympathetic paraganglioma ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine CancerNCT04394858
Advanced Adrena...
Advanced Paraga...
Metastatic Adre...
Metastatic Para...
Stage III Adren...
Stage IV Adrena...
Unresectable Ad...
Unresectable Pa...
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Olaparib
Quality-of-Life...
Temozolomide
18 Years - National Cancer Institute (NCI)
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine CancerNCT04394858
Advanced Adrena...
Advanced Paraga...
Metastatic Adre...
Metastatic Para...
Stage III Adren...
Stage IV Adrena...
Unresectable Ad...
Unresectable Pa...
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Olaparib
Quality-of-Life...
Temozolomide
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: